Chu De Quebec-universite Laval

This study compares two radiation treatments for early-stage prostate cancer to see which causes fewer side effects. Researchers will enroll 208 men with low or favorable intermediate-risk prostate cancer. One group receives targeted external radiation (SBRT), while the other rec…

This study aims to find the best level of protective antibodies to give patients with hard-to-treat multiple myeloma who are receiving a new type of immunotherapy. The new treatment can weaken the immune system, raising the risk of serious infections. Researchers are comparing wh…

This study is testing a new, lab-grown skin graft for people with Recessive Dystrophic Epidermolysis Bullosa (RDEB), a painful genetic condition that causes fragile, blistering skin. The graft is made from a patient's own skin cells, which are genetically corrected in a lab to pr…

This study is testing if an ultra-short course of radiation is as safe and effective as a moderately short course for treating localized prostate cancer. It will involve about 205 men and combines internal radiation (brachytherapy) with external beam radiation. The main goal is t…

This study is testing if adding a daily pill called bicalutamide to the standard BCG bladder wash treatment can better prevent cancer from returning. It will involve about 160 men with early-stage bladder cancer that hasn't spread into the muscle. Participants will be randomly as…

This study is testing if a simple, non-invasive nail exam can help doctors diagnose specific autoimmune diseases faster in patients with early, unclear symptoms. Researchers will compare two groups of 40 patients to see if getting this exam early leads to a clearer diagnosis with…

This study aims to see if a specific nerve block (paravertebral block) is better than standard pain medication at reducing pain after mastectomy with immediate reconstruction. Researchers will enroll 60 women to compare pain levels and opioid use in the first 72 hours after surge…